Animal healthcare company Sequent Scientific Limited announced the resignation of Sharat Pandurang Narasapur as Joint Managing Director of the company, with effect from April 30, 2024. According to the company’s exchange filing, “Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘SEBI Listing Regulations’) the Company hereby wishes to inform…
SeQuent Scientific Limited, a leading animal healthcare company, announced that Patri Venkat Raghavendra Rao has resigned from the role of Chief Financial Officer of the company, with effect from October 25, 2023. According to the company’s exchange filing, “We wish to inform you that Mr. Patri Venkat Raghavendra Rao, Chief Financial Officer and Key Managerial…
SeQuent Scientific Limited (SeQuent), India’s leading animal health company with a strong presence in veterinary formulations and APIs, has signed a definitive agreement on 07 November 2022 to acquire 100% stake in Tineta Pharma Private Limited (Tineta), a company incorporated in India. India is a strategic market for SeQuent, and this acquisition will give a…
SeQuent Scientific Limited (SeQuent), having businesses in animal health sector through its principal operating company “Alivira Animal Health Ltd. (Alivira)”, has completed the acquisition of 100% stake in Nourrie Saúde e Nutrição Animal Ltda (Nourrie) in Brazil. This acquisition has been made through Alivira Saúde Animal Ltda Brazil, a wholly owned subsidiary of Alivira, for…
SeQuent Scientific Limited (SeQuent), having businesses in animal health sector through its principal operating company “Alivira Animal Health Ltd.” (Alivira), has completed consolidation of its Brazilian operations by increasing its shareholding in Evance Group to 100% for an effective consideration of Rs. 446 million. Since acquisition by Alivira in 2016, Evance Group has grown at…
SeQuent Scientific Limited (SeQuent), having businesses in animal health sector through its principal operating company “Alivira Animal Health Ltd.”, announced it has signed a definitive agreement to acquire 100% stake in Nourrie Saúde e Nutrição Animal Ltda (Nourrie) in Brazil. In line with its stated strategy for Sequent 2.0, this acquisition marks Alivira’s foray into…
Global investment firm The Carlyle Group and the existing promoters of SeQuent Scientific Ltd, announced that CA Harbor Investments, an affiliated entity of CAP V Mauritius Ltd and The Carlyle Group, has agreed to acquire an equity stake of up to 74% in SeQuent Scientific Limited, the largest pure-play animal healthcare company in India. The…